HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

Platinum Equity Announces Sunrise Medical Acquisition
The investment firm purchased the seating and mobility manufacturer from Nordic Capital.

June 7, 2024 by Laurie Watanabe

Platinum Equity, a global investment firm headquartered in Los Angeles, has acquired Sunrise Medical, a seating and wheeled mobility manufacturer headquartered in Malsch, Germany, with American headquarters in Fresno, California.

In a June 5 press release, Platinum Equity stated it had purchased Sunrise Medical from Nordic Capital, which acquired Sunrise in 2015. Platinum Equity added that the acquisition is expected to be completed in the third quarter of this year. Financial terms were not disclosed.

Sunrise Medical President/CEO Thomas Babacan “will continue leading the company following the transition to new ownership,” the announcement said.

Babacan acknowledged Sunrise Medical’s growth under Nordic Capital’s ownership. Sunrise acquisitions during that time included all-terrain power chair manufacturer Magic Mobility in 2018 and seating manufacturer Ride Designs in 2023.

“For more than 40 years, we have been following our mission of improving people’s lives,” Babacan said in a June 5 statement posted to Sunrise’s website. “Nordic Capital’s deep sector expertise, focus on operational excellence, and experience in how to advance global expansion have been instrumental in the growth of Sunrise Medical over the past years. We are grateful for the excellent partnership which has enabled us to achieve our joint vision of creating a leader in our sector with an unrivalled global presence, to the benefit of users in need.”

Babacan added that Sunrise is ready for additional growth.

“Based on our strong global footprint and proven strengths in providing users and customers with high-quality products and services, coupled with continuous innovation, we are ideally positioned to capture further growth opportunities,” he noted. “While we have been ready to enter the next stage as a privately held or publicly listed company, we are delighted to welcome Platinum Equity as our future shareholder, which will enable us to continue innovating and growing with the support of private capital. Platinum has a lot of experience supporting complex, global businesses and the firm’s financial resources and operational expertise will be especially valuable to our mission. Improving the lives of users in need will remain our focus, and we are excited about the opportunities to be impactful on an even larger scale.”

“Sunrise Medical has established an impressive global network serving the mobility needs of people around the world,” said Platinum Equity Managing Director Igor Chacartegui. “We will continue investing in organic growth and also pursue acquisitions that can expand or fill in gaps in the company’s product line, provide new technological capabilities, or further extend the company’s geographic reach.”

Platinum Equity was founded by Tom Gores in 1995 and currently has more than $48 billion of assets under management globally. The organization’s portfolio comprises approximately 50 companies and employs 190,000 people in a number of industries, including manufacturing, distribution, transportation and logistics, equipment rentals, metals services, media and entertainment, technology and telecommunications.

Related Articles Read More >

Inogen Reports Continued Revenue Growth, Leans Into International Markets During Q3 Earnings Call
The company's "turnaround strategy" remains on target, CEO Kevin Smith said.
Final Physician Fee Schedule: CMS Touts Cost Savings, Reduced Waste with Major Changes to Skin Substitutes Policy
The new incident-to-supplies payment structure is accompanied by a cap for skin substitute reimbursement.
For HME Providers, the Real AI Challenge Is Often Cultural, Not Technical
Misunderstanding and fear of how artificial intelligence will be implemented are common employee concerns.
New NCPA Tool Maps Pharmacy Shortages Nationwide
Tool can be used by community advocates, policymakers and other members of the public.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe